Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

The primary support for the proposed indication came from the phase III CAPItello-281 trial, where the addition of capivasertib demonstrated a 7.5-month median improvement in radiographic ...

A controller of sexual reproduction and urination: We take a look at this commonly overlooked part of the male body. Hidden deep in the body, changes often go unnoticed until problems begin. The ...

The therapeutic landscape of metastatic castration-resistant prostate cancer (mCRPC) has evolved substantially over the past decade, with androgen receptor pathway inhibitors, taxanes, poly ...

Video released Thursday shows the suspect in the shooting during the White House Correspondents’ Association dinner appearing to shoot a Secret Service officer as he sprints through a security ...

FDA's independent advisors on Thursday endorsed the use of capivasertib (Truqap) for treating an aggressive subtype of prostate cancer. By a 7-1 vote, and with a single abstention, the Oncologic Drugs ...

Discover how Seeking Alpha Premium uses advanced screening, research, and tracking tools to drive confident investment decisions. Learn to navigate key Premium capabilities and stay ahead of market ...